The balance of positive and negative effects of TGF-β signaling regulates the development of hematopoietic and endothelial progenitors in human pluripotent stem cells

Hao Bai, Yin Liang Xie, Yong Xing Gao, Tao Cheng, Zack Z. Wang

Research output: Contribution to journalArticle

Abstract

Derived from mesoderm precursors, hemangioblasts are bipotential common progenitors of hematopoietic cells and endothelial cells. The regulatory events controlling hematopoietic and endothelial lineage specification are largely unknown, especially in humans. In this study, we establish a serum-free and feeder-free system with a high-efficient embryoid body (EB) generation to investigate the signals that direct differentiation of human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs). Consistent with previous studies, the CD34 +CD31+VE-cadherin+ (VEC+) cells derived from hPSCs contain hematopoietic and endothelial progenitors. In the presence of hematopoietic and endothelial growth factors, some of CD34 +CD31+VEC+ cells give rise to blast colony-forming cells (BL-CFCs), which have been used to characterize bipotential hemangioblasts. We found that the level of the transforming growth factor beta (TGF-β) 1 protein is increased during hPSC differentiation, and that TGF-β signaling has the double-edged effect on hematopoietic and endothelial lineage differentiation in hPSCs. An addition of TGF-β to hPSC differentiation before mesoderm induction promotes the development of mesoderm and the generation of CD34+CD31+VEC+ cells. An addition of TGF-β inhibitor, SB431542, before mesoderm induction downregulates the expression of mesodermal markers and reduces the number of CD34+CD31+VEC+ progenitor cells. However, inhibition of TGF-β signaling after mesoderm induction increases CD34 +CD31+VEC+ progenitors and BL-CFCs. These data provide evidence that a balance of positive and negative effects of TGF-β signaling at the appropriate timing is critical, and potential means to improve hematopoiesis and vasculogenesis from hPSCs.

Original languageEnglish (US)
Pages (from-to)2765-2776
Number of pages12
JournalStem Cells and Development
Volume22
Issue number20
DOIs
StatePublished - Oct 15 2013

Fingerprint

Pluripotent Stem Cells
Transforming Growth Factor beta
Mesoderm
Hemangioblasts
Cell Differentiation
Endothelial Growth Factors
Embryoid Bodies
Induced Pluripotent Stem Cells
Hematopoiesis
Hematopoietic Stem Cells
Stem Cells
Down-Regulation
Endothelial Cells
cadherin 5
Serum

ASJC Scopus subject areas

  • Cell Biology
  • Developmental Biology
  • Hematology

Cite this

The balance of positive and negative effects of TGF-β signaling regulates the development of hematopoietic and endothelial progenitors in human pluripotent stem cells. / Bai, Hao; Xie, Yin Liang; Gao, Yong Xing; Cheng, Tao; Wang, Zack Z.

In: Stem Cells and Development, Vol. 22, No. 20, 15.10.2013, p. 2765-2776.

Research output: Contribution to journalArticle

@article{165cc400e496431ca22a561416dde568,
title = "The balance of positive and negative effects of TGF-β signaling regulates the development of hematopoietic and endothelial progenitors in human pluripotent stem cells",
abstract = "Derived from mesoderm precursors, hemangioblasts are bipotential common progenitors of hematopoietic cells and endothelial cells. The regulatory events controlling hematopoietic and endothelial lineage specification are largely unknown, especially in humans. In this study, we establish a serum-free and feeder-free system with a high-efficient embryoid body (EB) generation to investigate the signals that direct differentiation of human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs). Consistent with previous studies, the CD34 +CD31+VE-cadherin+ (VEC+) cells derived from hPSCs contain hematopoietic and endothelial progenitors. In the presence of hematopoietic and endothelial growth factors, some of CD34 +CD31+VEC+ cells give rise to blast colony-forming cells (BL-CFCs), which have been used to characterize bipotential hemangioblasts. We found that the level of the transforming growth factor beta (TGF-β) 1 protein is increased during hPSC differentiation, and that TGF-β signaling has the double-edged effect on hematopoietic and endothelial lineage differentiation in hPSCs. An addition of TGF-β to hPSC differentiation before mesoderm induction promotes the development of mesoderm and the generation of CD34+CD31+VEC+ cells. An addition of TGF-β inhibitor, SB431542, before mesoderm induction downregulates the expression of mesodermal markers and reduces the number of CD34+CD31+VEC+ progenitor cells. However, inhibition of TGF-β signaling after mesoderm induction increases CD34 +CD31+VEC+ progenitors and BL-CFCs. These data provide evidence that a balance of positive and negative effects of TGF-β signaling at the appropriate timing is critical, and potential means to improve hematopoiesis and vasculogenesis from hPSCs.",
author = "Hao Bai and Xie, {Yin Liang} and Gao, {Yong Xing} and Tao Cheng and Wang, {Zack Z.}",
year = "2013",
month = "10",
day = "15",
doi = "10.1089/scd.2013.0008",
language = "English (US)",
volume = "22",
pages = "2765--2776",
journal = "Stem Cells and Development",
issn = "1547-3287",
publisher = "Mary Ann Liebert Inc.",
number = "20",

}

TY - JOUR

T1 - The balance of positive and negative effects of TGF-β signaling regulates the development of hematopoietic and endothelial progenitors in human pluripotent stem cells

AU - Bai, Hao

AU - Xie, Yin Liang

AU - Gao, Yong Xing

AU - Cheng, Tao

AU - Wang, Zack Z.

PY - 2013/10/15

Y1 - 2013/10/15

N2 - Derived from mesoderm precursors, hemangioblasts are bipotential common progenitors of hematopoietic cells and endothelial cells. The regulatory events controlling hematopoietic and endothelial lineage specification are largely unknown, especially in humans. In this study, we establish a serum-free and feeder-free system with a high-efficient embryoid body (EB) generation to investigate the signals that direct differentiation of human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs). Consistent with previous studies, the CD34 +CD31+VE-cadherin+ (VEC+) cells derived from hPSCs contain hematopoietic and endothelial progenitors. In the presence of hematopoietic and endothelial growth factors, some of CD34 +CD31+VEC+ cells give rise to blast colony-forming cells (BL-CFCs), which have been used to characterize bipotential hemangioblasts. We found that the level of the transforming growth factor beta (TGF-β) 1 protein is increased during hPSC differentiation, and that TGF-β signaling has the double-edged effect on hematopoietic and endothelial lineage differentiation in hPSCs. An addition of TGF-β to hPSC differentiation before mesoderm induction promotes the development of mesoderm and the generation of CD34+CD31+VEC+ cells. An addition of TGF-β inhibitor, SB431542, before mesoderm induction downregulates the expression of mesodermal markers and reduces the number of CD34+CD31+VEC+ progenitor cells. However, inhibition of TGF-β signaling after mesoderm induction increases CD34 +CD31+VEC+ progenitors and BL-CFCs. These data provide evidence that a balance of positive and negative effects of TGF-β signaling at the appropriate timing is critical, and potential means to improve hematopoiesis and vasculogenesis from hPSCs.

AB - Derived from mesoderm precursors, hemangioblasts are bipotential common progenitors of hematopoietic cells and endothelial cells. The regulatory events controlling hematopoietic and endothelial lineage specification are largely unknown, especially in humans. In this study, we establish a serum-free and feeder-free system with a high-efficient embryoid body (EB) generation to investigate the signals that direct differentiation of human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs). Consistent with previous studies, the CD34 +CD31+VE-cadherin+ (VEC+) cells derived from hPSCs contain hematopoietic and endothelial progenitors. In the presence of hematopoietic and endothelial growth factors, some of CD34 +CD31+VEC+ cells give rise to blast colony-forming cells (BL-CFCs), which have been used to characterize bipotential hemangioblasts. We found that the level of the transforming growth factor beta (TGF-β) 1 protein is increased during hPSC differentiation, and that TGF-β signaling has the double-edged effect on hematopoietic and endothelial lineage differentiation in hPSCs. An addition of TGF-β to hPSC differentiation before mesoderm induction promotes the development of mesoderm and the generation of CD34+CD31+VEC+ cells. An addition of TGF-β inhibitor, SB431542, before mesoderm induction downregulates the expression of mesodermal markers and reduces the number of CD34+CD31+VEC+ progenitor cells. However, inhibition of TGF-β signaling after mesoderm induction increases CD34 +CD31+VEC+ progenitors and BL-CFCs. These data provide evidence that a balance of positive and negative effects of TGF-β signaling at the appropriate timing is critical, and potential means to improve hematopoiesis and vasculogenesis from hPSCs.

UR - http://www.scopus.com/inward/record.url?scp=84885159556&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84885159556&partnerID=8YFLogxK

U2 - 10.1089/scd.2013.0008

DO - 10.1089/scd.2013.0008

M3 - Article

C2 - 23758278

AN - SCOPUS:84885159556

VL - 22

SP - 2765

EP - 2776

JO - Stem Cells and Development

JF - Stem Cells and Development

SN - 1547-3287

IS - 20

ER -